Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Leveraging multi-omics approaches to understand hematopoietic stem cells in myeloid malignancies


Stephen Chung, MD, University of Texas Southwestern
Description

Understanding the mechanisms that allow clonal hematopoietic stem cells (HSCs) to expand and cause disease will be critical for developing strategies to identify patients at high risk for adverse clinical outcomes who may benefit from pre-emptive interventions. A major limitation to such studies is the fact that clonal HSCs are often present at low frequencies and intermixed with their unmutated counterparts. Stephen Chung, MD, of the University of Texas Southwestern Medical Center discusses his team’s efforts to overcome this limitation by identifying cell surface markers present on clonal HSCs that will allow them to prospectively purify them for further functional and molecular studies.



VIEW


Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Single Cell Core Facility Services at Josep Carreras Institute
Caterina Mata Garcia, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
EU Heme Symposium Panel Discussion
Manel Esteller, MD, PhD
Maria Paola Martelli, MD PhD, Renee Beekman, PhD
Ferran Nadeu, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
Sarah Meyers, PhD
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE